TFF Pharmaceuticals Inc (TFFP) Stock Balance Sheet
NASDAQ:TFFP - Nasdaq - US87241J2033 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 2.61M | 5.48M | 16.61M | 33.79M | 35.30M | |||
| Receivables | 309.83K | 433.85K | 190.00K | 2.60M | N/A | |||
| Other Current Assets | 592.14K | 1.68M | 2.23M | 2.45M | 2.26M | |||
| Total Current Assets | 3.51M | 7.59M | 19.03M | 38.84M | 37.56M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.70M | 2.12M | 3.27M | 1.86M | 1.10M | |||
| Investments And Advances | 1.78M | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 95.32K | 7.69K | 10.00K | N/A | N/A | |||
| Total Non-Current Assets | 3.57M | 4.44M | 5.09M | 1.86M | 1.10M | |||
| TOTAL ASSETS | 7.08M | 12.03M | 24.12M | 40.70M | 38.66M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 2.05M | 1.37M | 90.00K | 420.00K | N/A | |||
| Accounts Payable | 1.64M | 958.44K | 920.00K | 1.49M | 1.30M | |||
| Other Current Liabilities | 250.70K | 101.00K | 130.00K | 50.00K | 20.00K | |||
| Total Current Liabilities | 3.94M | 2.43M | 1.13M | 1.96M | 1.32M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | N/A | 31.74K | 110.00K | N/A | 0.00 | |||
| Total Non-Current Liabilities | 0.00 | 31.74K | 110.00K | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 3.94M | 2.46M | 1.24M | 1.96M | 1.32M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -132.09M | -118.33M | -97.09M | -65.32M | -34.28M | |||
| Additional Paid In Capital | 135.39M | 128.04M | 120.07M | 104.08M | 71.65M | |||
| Common Shares | 3.54K | 2.37K | 40.00K | 30.00K | 20.00K | |||
| Other Shareholders' Equity | -166.65K | -148.19K | -140.00K | -50.00K | -50.00K | |||
| Shares Outstanding | 3.54M | 2.37M | 36.19M | 25.37M | 22.53M | |||
| Tangible Book Value per Share | 0.89 | 4.04 | 0.63 | 1.53 | 1.66 | |||
| Total Shareholders' Equity | 3.14M | 9.57M | 22.88M | 38.74M | 37.34M | |||
| TOTAL LIABILITIES AND EQUITY | 7.08M | 12.03M | 24.12M | 40.70M | 38.66M | |||
| Statistics | ||||||||
| Current Ratio | 0.89 | 3.13 | 16.84 | 19.82 | 28.45 | |||
| Return On Assets (ROA) | -261.68% | -176.62% | -131.72% | -76.27% | -48.03% | |||
| Return On Equity (ROE) | -590.38% | -222.05% | -138.85% | -80.12% | -49.73% | |||
All data in USD , ROIC based on taxRate of 0.21